The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cardiac Sympathetic Denervation in Parkinson Disease
Abstract
BACKGROUND: In Parkinson disease, orthostatic hypotension can result from L-dopa treatment or from sympathetic neurocirculatory failure. The latter is detected by abnormal blood pressure responses to the Valsalva maneuver and can be associated with loss of functional cardiac sympathetic nerve terminals. OBJECTIVE: To determine the frequency of cardiac sympathetic denervation in Parkinson disease, with or without sympathetic neurocirculatory failure, and its association with disease duration, severity, and L-dopa treatment DESIGN: Intergroup comparisons in resting patients. SETTING: National Institutes of Health Clinical Center, Bethesda, Maryland. PATIENTS: 29 patients with Parkinson disease (9 with sympathetic neurocirculatory failure, 10 who had stopped receiving or had never been treated with L-dopa), 24 patients with multiple-system atrophy (17 with sympathetic neurocirculatory failure, 8 receiving L-dopa), 7 patients with pure autonomic failure, 33 controls with episodic or persistent orthostatic intolerance without sympathetic neurocirculatory failure, and 19 normal volunteers. MEASUREMENTS: Beat-to-beat blood pressure responses to the Valsalva maneuver, interventricular septal 6-[18F]fluorodopamine-derived radioactivity, cardiac extraction fraction of [3H]norepinephrine, appearance rate of norepinephrine in coronary sinus plasma (cardiac norepinephrine spillover) and venous-arterial differences in levels of dihydroxyphenylglycol (DHPG) and endogenous L-dopa. RESULTS: Of the 29 patients with Parkinson disease, 9 with sympathetic neurocirculatory failure and 11 without had low septal 6-[18F]fluorodopamine-derived radioactivity (2861 +/- 453 Bq/mL per MBq/kg and 5217 +/- 525 Bq/mL per MBq/kg, respectively). All 6 patients with Parkinson disease and decreased 6-[18F]fluorodopamine-derived radioactivity who underwent right-heart catheterization had a decreased cardiac extraction fraction of [3H]norepinephrine and virtually no cardiac norepinephrine spillover or venous-arterial increments in plasma levels of DHPG and L-dopa. Sympathetic neurocirculatory failure and decreased 6-[18F]fluorodopamine-derived radioactivity were unrelated to disease duration, disease severity, or L-dopa treatment CONCLUSIONS: Many patients with Parkinson disease-including all those with sympathetic neurocirculatory failure-have evidence of cardiac sympathetic denervation. This suggests that loss of catecholamine innervation in Parkinson disease occurs in the nigrostriatal system in the brain and in the sympathetic nervous system in the heart
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LANGLEY, J. N. (1903) · Brain · doi:10.1093/brain/26.1.1 · Cited by 1,656
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C., Kaufmann, H., Klockgether, T., Lang, A., Lantos, P., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,308
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 956
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
An introduction to the free radical hypothesis in Parkinson's disease
Olanow, C. W. (1992) · Annals of Neurology · doi:10.1002/ana.410320703 · Cited by 382
Prevalence of orthostatic hypotension in Parkinson's disease
Senard, J. M., Rai, S., Lapeyre-Mestre, M., Brefel, C., Rascol, O., Rascol, A., & Montastruc, J. L. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.584 · Cited by 369
123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease
Orimo, S., Ozawa, E., Nakade, S., Sugimoto, T., & Mizusawa, H. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.2.189 · Cited by 356
Sympathetic Cardioneuropathy in Dysautonomias
Goldstein, D. S., Holmes, C., Cannon, R. O., Eisenhofer, G., & Kopin, I. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361004 · Cited by 324
Self-citationCardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy
Braune, S., Reinhardt, M., Schnitzer, R., Riedel, A., & Lücking, C. H. (1999) · Neurology · doi:10.1212/wnl.53.5.1020 · Cited by 322
Pharmacologic distinction of different orthostatic hypotension syndromes
Polinsky, R. J., Kopin, I. J., Ebert, M. H., & Weise, V. (1981) · Neurology · doi:10.1212/wnl.31.1.1 · Cited by 296
Cited by
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072
“Loss of sympathetic innervation is most pronounced in the heart and occurs in both familial and sporadic forms of the disease (Taki et al., 2000; Goldstein et al., 2000, 2001).”
BackgroundSelf-citationParkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Goldstein, D. S., Bentho, O., Park, M.-Y., & Sharabi, Y. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.056259 · Cited by 846
“…disease with orthostatic hypotension have neuroimaging, neurochemical and postmortem neuropathological evidence of cardiac sympathetic denervation (Goldstein et al. 2000; Goldstein & Orimo, 2009), whereas most patients with multiple system atrophy have intact cardiac sympathetic innervation…”
BackgroundSelf-citation
Metadata
- Authors
- Goldstein, D. S., Holmes, C., Li, S.-T., Bruce, S., Metman, L. V., & Cannon, R. O.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-09-05
- Volume
- 133
- Issue
- 5
- Pages
- 338-347
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2094591619
- Cited by
- 371
- References
- 39
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac Sympathetic Denervation in Parkinson Disease. https://app.cochat.ai/papers/10.7326/0003-4819-133-5-200009050-00009
- The paper
- Goldstein, D. S., Holmes, C., Li, S.-T., Bruce, S., Metman, L. V., & Cannon, R. O. (2000). Cardiac Sympathetic Denervation in Parkinson Disease. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-5-200009050-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.